Cointime

Inflammatix

company

About

Inflammatix develops novel molecular diagnostics for acute infections and sepsis that work by reading the immune system.

  • 51 - 100

Highlights

Total Funding Amount
$1.70M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.70M
Industries
Big Data,Bioinformatics,Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2016
Number Of Employee
51 - 100
Operating Status
Active

Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges.

They are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University.

The company was founded by Timothy Sweeney and Jonathan Romanowsky in California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.70M
Inflammatix has raised a total of $1.70M in funding over 2 rounds. Their latest funding was raised on Nov 11, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 11, 2021 Grant $1.70M 1 National Institutes of Health — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Inflammatix is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cointime
Chủ Đề
Công Ty